K2 Hampton™

K2 Hampton is the new way to manage blood pressure in pregnancy in a digital age.

It enables women with hypertension to remotely enter blood pressure and urine protein results from home and work, prompting them to contact their midwife when they enter an out of range result.

“Hampton is really working well for women and clinicians and saved 26 hours of staff time in first week alone.”

Wendy Knight, Hampton Admin, North Manchester General Hospital

K2 Hampton is a registered class I medical device and is registered with the MHRA. Evidence can be made available on request.

 

View our Knowledge Base

Remote Monitoring

With K2 Hampton, The results can be viewed by the clinician in real time in hospital, highlighting results that require attention and allowing them to record actions that have occurred as a direct consequence. K2 Hampton blood pressure ranges default to the NICE cg107 guideline for hypertension in pregnancy. However, the clinician can also adapt these ranges individually for each woman to ensure that it is personalised for her needs.

Benefits

K2 Hampton is designed with both patients and clinicians in mind. This carries benefits such as enhanced usability for all, greater communication and knowledge sharing and tailored care to meet the individual of each and every woman.

• Prevents the need for un-required hospital visits
• Alerts the woman if she needs to call her clinician
• Visually appealing and intuitive
• Tailored for  each woman
• Enhances and facilitates communication between the woman and her clinicians
• Accessible from any location, from any device with an internet connection
• Secure, accurate and up to date at all time
• Easy and straightforward to implement

Money Saving

K2 Hampton provides a platform that saves time for both women and their clinicians, freeing up time for other tasks. As a direct consequence, it also saves money. An independent economic review found that K2 Hampton can save up to £966.97 per woman compared to traditional monitoring*. This study did not include any additional cost savings associated with the woman herself.

“*Independent Evaluation by York Health Economics Consortium.”